Auragens Selected as Top Stem Cell Treatment Center Worldwide

Life Sciences Review Names Auragens Best in Class Following a Comprehensive Review of the Science, Biologics, Safety Profile, Medical Team, Patient Experience and Patient Outcomes

PANAMA CITY & LAS VEGAS--(BUSINESS WIRE)-- Auragens, an established leader in Stem Cell research, development and treatment, has been singled out as the best facility for stem cell treatments, globally. A further recognition of their leadership in the field and their dedication to regenerative medicine.

This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250812756906/en/

Welcome Lobby at Auragens

“While stem cell therapy and regenerative medicine hold immense promise, the field remains vulnerable to misinformation, pseudoscience and bad actors who exploit hope without ensuring safety or delivering results… Auragens bridges that gap by anchoring its work in hard science, rigorous ethics, and irrefutable outcomes,” stated Life Sciences Review.

Auragens set itself apart in the industry through its transparency and openness with more traditional healthcare practitioners and academia. By inviting numerous, well-respected third parties to their center to provide oversight, facilitate collaboration and innovation, and document without bias all patient outcomes, Auragens has greatly benefited from an interdisciplinary cohort of experts who are mission driven to improve the quality of life for their patients.

“A recognition such as this, is yet another reminder to the entire organization that our firm commitment to excellence, and to our patients, is seen and appreciated by our peers in other specialties,” said Auragens CEO Dr. Dan Briggs. “The field of stem cell treatments is rapidly expanding, and we appreciate Life Sciences Review’s awareness that a proactive approach must be taken to separate the truth from the fiction in medical care and patient options.”

Auragens has received numerous commendations and prestigious recognitions for their work in this field from awards to keynote presentations to published papers to best-selling books. But what has driven the success is the patient-centric focus on results. The core mission of changing the trust relationship between regenerative medicine and those who will benefit, establishing the standard of care and predictable outcomes that must become a requirement for all in the field. Being recognized for the quality of the treatments, through tireless scientific and medical work, is another powerful step in this continued evolution to benefit all mankind.

About Auragens – Auragens is the market leader in the field of stem cell treatments, research, and development. They operate their own laboratory onsite and are ISO certified while pursuing AABB accreditation and following all cGMP guidelines and FDA related regulations for safety. Treatments are provided at their private state-of-the-art facility in Panama City, Panama and spans the entire 48th floor of a Class A office building in the Beverly Hills of Panama City, known as Punta Pacifica. All science and medicine are overseen by a team of doctors hailing from universities such as Johns Hopkins, Stanford and Notre Dame among others. Published in numerous journals, recipient of Medical Researcher of the Year and Business of the Year, Auragens is leading in cutting edge Regenerative Medicine with a goal of making their treatments a Standard of Care and available to all in need.

For more information: http://www.Auragens.com email us: [email protected] or call us: +1-844-888-6717

View source version on businesswire.com: https://www.businesswire.com/news/home/20250812756906/en/

[email protected]
+1-844-888-6717

Source: Auragens

You May Also Be Interested In

• Hunting PLC (“Hunting” or “the Company” or “the Group”) Results for the Six Months Ended 30 June 2026
• Hafnia’s Q2 2026 Financial Results Presentation to Be Held on 28 August 2026
• Pepe Price Climbs as BONK Revenue Explodes to $1.16M – Could Apeing Be the Upcoming Crypto Coin to Watch for High Upside